RaQualia Pharma Inc. (4579)
Market Closed
12 Aug, 06:00
JPX JPX Primary ¥
517. 00
+2
+0.3883%
¥
22.11B Market Cap
- P/E Ratio
- Div Yield
91,800 Volume
- Eps
¥ 515
Previous Close Want to track 4579 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RaQualia Pharma Inc. (4579) Statistics
Valuation metrics
Market Cap 22.11B
Enterprise value 11.04B
Trailing P/E (ttm) 175.34
Forward P/E 21.3
PEG ratio -2.57
Price/Sales (ttm) 3.33
Price/Book (mrq) 1.64
Enterprise Value/Revenue 2.89
Enterprise Value/EBITDA 15.22
Overview
Shares outstanding 24.46M
Float 17.4M
Shares short -
% Held by insiders 0.32%
% Held by institutions 0.02%
Average volume (10 days) 113.15K
Average volume (90 days) 208.76K
Price summary
52-Week low 438
52-Week high 1,465
Beta 0.94
50-Day moving average 476.94
200-Day moving average 723.51
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin 0.01%
Operating margin 0.06%
Operational effectiveness
Return on assets 0%
Return on equity 0.01%
Income Statement
Revenue (ttm) 3.98B
Revenue per share (ttm) 149.48
Quarterly revenue growth (yoy) 1.26%
Gross profit (ttm) 3.27B
EBITDA 958.96M
Net income to common (ttm) 273M
Diluted EPS (ttm) 2.06
Quarterly earnings growth (yoy) 0.18%
Balance Sheet
Total cash (mrq) 3.24B
Total cash per share (mrq) 176.03
Total debt (mrq) 2.9B
Total Debt/Equity (mrq) 0.34
Current ratio (mrq) 6.16%
Book value per share (mrq) 316.72
Cash Flow
Cash flow statement -354M
Levered free cash flow (LFCF) -485M
